168 related articles for article (PubMed ID: 35567430)
1. Prostate health index (PHI) as a reliable biomarker for prostate cancer: a systematic review and meta-analysis.
Agnello L; Vidali M; Giglio RV; Gambino CM; Ciaccio AM; Lo Sasso B; Ciaccio M
Clin Chem Lab Med; 2022 Jul; 60(8):1261-1277. PubMed ID: 35567430
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic ability of %p2PSA and prostate health index for aggressive prostate cancer: a meta-analysis.
Wang W; Wang M; Wang L; Adams TS; Tian Y; Xu J
Sci Rep; 2014 May; 4():5012. PubMed ID: 24852453
[TBL] [Abstract][Full Text] [Related]
3. Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy.
Perdonà S; Bruzzese D; Ferro M; Autorino R; Marino A; Mazzarella C; Perruolo G; Longo M; Spinelli R; Di Lorenzo G; Oliva A; De Sio M; Damiano R; Altieri V; Terracciano D
Prostate; 2013 Feb; 73(3):227-35. PubMed ID: 22821756
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Accuracy of Liquid Biomarkers for Clinically Significant Prostate Cancer Detection: A Systematic Review and Diagnostic Meta-analysis of Multiple Thresholds.
Kawada T; Shim SR; Quhal F; Rajwa P; Pradere B; Yanagisawa T; Bekku K; Laukhtina E; von Deimling M; Teoh JY; Karakiewicz PI; Araki M; Shariat SF
Eur Urol Oncol; 2023 Nov; ():. PubMed ID: 37981495
[TBL] [Abstract][Full Text] [Related]
5. The prostate health index (PHI) density: Are there advantages over PHI or over the prostate-specific antigen density?
Garrido MM; Ribeiro RM; Pinheiro LC; Holdenrieder S; Guimarães JT
Clin Chim Acta; 2021 Sep; 520():133-138. PubMed ID: 34097882
[TBL] [Abstract][Full Text] [Related]
6. Incorporating PHI in decision making: external validation of the Rotterdam risk calculators for detection of prostate cancer.
Rius Bilbao L; Aguirre Larracoechea U; Valladares Gomez C; Remmers S; Mar Medina C;
World J Urol; 2024 Mar; 42(1):141. PubMed ID: 38478041
[TBL] [Abstract][Full Text] [Related]
7. Molecular Biomarkers for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis.
Del Pino-Sedeño T; Infante-Ventura D; de Armas Castellano A; de Pablos-Rodríguez P; Rueda-Domínguez A; Serrano-Aguilar P; Trujillo-Martín MM
Eur Urol Open Sci; 2022 Dec; 46():105-127. PubMed ID: 36388432
[TBL] [Abstract][Full Text] [Related]
8. A Systematic Review and Meta-analysis of the Diagnostic Accuracy of Prostate Health Index and 4-Kallikrein Panel Score in Predicting Overall and High-grade Prostate Cancer.
Russo GI; Regis F; Castelli T; Favilla V; Privitera S; Giardina R; Cimino S; Morgia G
Clin Genitourin Cancer; 2017 Aug; 15(4):429-439.e1. PubMed ID: 28111174
[TBL] [Abstract][Full Text] [Related]
9. Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection.
Barisiene M; Bakavicius A; Stanciute D; Jurkeviciene J; Zelvys A; Ulys A; Vitkus D; Jankevicius F
Biomed Res Int; 2020; 2020():9872146. PubMed ID: 32775459
[TBL] [Abstract][Full Text] [Related]
10. New strategy for the identification of prostate cancer: The combination of Proclarix and the prostate health index.
Terracciano D; La Civita E; Athanasiou A; Liotti A; Fiorenza M; Cennamo M; Crocetto F; Tennstedt P; Schiess R; Haese A; Ferro M; Steuber T
Prostate; 2022 Nov; 82(15):1469-1476. PubMed ID: 35971798
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of the prostate health index versus the urinary prostate cancer antigen 3 score to predict overall and significant prostate cancer at initial biopsy.
Seisen T; Rouprêt M; Brault D; Léon P; Cancel-Tassin G; Compérat E; Renard-Penna R; Mozer P; Guechot J; Cussenot O
Prostate; 2015 Jan; 75(1):103-11. PubMed ID: 25327361
[TBL] [Abstract][Full Text] [Related]
12. Clinical use of [-2]proPSA (p2PSA) and its derivatives (%p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literature.
Abrate A; Lughezzani G; Gadda GM; Lista G; Kinzikeeva E; Fossati N; Larcher A; Dell'Oglio P; Mistretta F; Buffi N; Guazzoni G; Lazzeri M
Korean J Urol; 2014 Jul; 55(7):436-45. PubMed ID: 25045441
[TBL] [Abstract][Full Text] [Related]
13. The Percentage of [-2]Pro-Prostate-Specific Antigen and the Prostate Health Index Outperform Prostate-Specific Antigen and the Percentage of Free Prostate-Specific Antigen in the Detection of Clinically Significant Prostate Cancer and Can Be Used as Reflex Tests.
Garrido MM; Marta JC; Bernardino RM; Guerra J; Fernandes F; Pereira MH; Ribeiro R; Holdenrieder S; Pinheiro LC; Guimarães JT
Arch Pathol Lab Med; 2022 Jun; 146(6):691-700. PubMed ID: 34343237
[TBL] [Abstract][Full Text] [Related]
14. Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers.
Ferro M; Bruzzese D; Perdonà S; Mazzarella C; Marino A; Sorrentino A; Di Carlo A; Autorino R; Di Lorenzo G; Buonerba C; Altieri V; Mariano A; Macchia V; Terracciano D
Clin Chim Acta; 2012 Aug; 413(15-16):1274-8. PubMed ID: 22542564
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer.
Boo Y; Chung JH; Kang M; Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Lee HM; Song W
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509551
[TBL] [Abstract][Full Text] [Related]
16. A panel of selected serum protein biomarkers for the detection of aggressive prostate cancer.
Song J; Ma S; Sokoll LJ; Eguez RV; Höti N; Zhang H; Mohr P; Dua R; Patil D; May KD; Williams S; Arnold R; Sanda MG; Chan DW; Zhang Z
Theranostics; 2021; 11(13):6214-6224. PubMed ID: 33995654
[No Abstract] [Full Text] [Related]
17. Diagnostic accuracy of prostate health index to identify aggressive prostate cancer. An Institutional validation study.
Morote J; Celma A; Planas J; Placer J; Ferrer R; de Torres I; Pacciuci R; Olivan M
Actas Urol Esp; 2016; 40(6):378-85. PubMed ID: 26923032
[TBL] [Abstract][Full Text] [Related]
18. Prostate health index vs percent free prostate-specific antigen for prostate cancer detection in men with "gray" prostate-specific antigen levels at first biopsy: systematic review and meta-analysis.
Bruzzese D; Mazzarella C; Ferro M; Perdonà S; Chiodini P; Perruolo G; Terracciano D
Transl Res; 2014 Dec; 164(6):444-51. PubMed ID: 25035153
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of prostate health index (PHI) in predicting prostate cancer on prostate biopsy.
Othman H; Abu Yamin AH; Md Isa N; Bahadzor B; Syed Zakaria SZ
Malays J Pathol; 2020 Aug; 42(2):209-214. PubMed ID: 32860373
[TBL] [Abstract][Full Text] [Related]
20. How to make clinical decisions to avoid unnecessary prostate screening in biopsy-naïve men with PI-RADs v2 score ≤ 3?
Zhang Y; Zeng N; Zhang F; Huang Y; Tian Y
Int J Clin Oncol; 2020 Jan; 25(1):175-186. PubMed ID: 31473884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
